Your session is about to expire
← Back to Search
Exercise Training for Cardiovascular Disease (CIED-EX Trial)
CIED-EX Trial Summary
This trial will investigate the effects of HIIT vs. MICT on physical, mental and quality of life of women with CIEDs, using a mixed-methods approach.
CIED-EX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CIED-EX Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to sign a consent form.I am a woman with a cardiac implant for over 6 months.I cannot or will not return for follow-ups at week 12.I am a woman with a well-functioning cardiac device and on optimal medical therapy.I have been diagnosed with unstable chest pain.I do not want to be randomly assigned to high-intensity or moderate-intensity exercise.I have been diagnosed with COPD, severe heart valve disease, or thickened heart muscle.
- Group 1: Standard care + moderate-intensity continuous exercise training (MICT)
- Group 2: Standard care + high-intensity interval training (HIIT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still an opportunity for volunteers to join this trial?
"According to the information available on clinicaltrials.gov, this medical trial is no longer accepting applicants. It was originally posted on August 1st 2023 but has not been updated since July 5th of that same year. Despite its closure, there are still 455 other studies actively recruiting participants at present."
What key aims does this research endeavor hope to achieve?
"This study will monitor its primary measurable outcome, the feasibility of attending classes, at Week 12. Several secondary objectives are also in place to evaluate patient quality-of-life via a 36 item survey; levels of anxiety through an established 7 question assessment; and cardiometabolic health indicators such as resting systolic/diastolic blood pressure."
Share this study with friends
Copy Link
Messenger